Skip to main content
Watch Insiders

Corporate insider profile

Jula Inrig Insider Trades

Latest reported as EVP, Head of R&D & CMO of Travere Therapeutics, Inc. (TVTX).

Purchase filings
0
Reported companies
1
Net open-market value
-$4,146,000.19
Latest transaction
Sep 15, 2026

Affiliated corporations

Reported company relationships

TVTXLatest reported

Travere Therapeutics, Inc.

EVP, Head of R&D & CMO

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 15, 2026Travere Therapeutics, Inc. (TVTX)EVP, Head of R&D & CMOSale44,674$62.34$2,785,022
May 6, 2026Travere Therapeutics, Inc. (TVTX)CHIEF MEDICAL OFFICERSale22,485$45.15$1,015,085
Apr 15, 2026Travere Therapeutics, Inc. (TVTX)CHIEF MEDICAL OFFICERSale8,233$42.01$345,893